Novel non-electrostatic valved holding chamber (VHC) has comparable in vitro performance for delivery of beta-2 agonist as similar-sized, pre-washed but non-conducting VHC

M. W. Nagel, K. J. Wiersema, C. C. Doyle, J. P. Mitchell, R. Sharpe (London, Canada; Nottingham, United Kingdom)

Source: Annual Congress 2006 - Evaluation of drugs for lung disease
Session: Evaluation of drugs for lung disease
Session type: Thematic Poster Session
Number: 1257
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. W. Nagel, K. J. Wiersema, C. C. Doyle, J. P. Mitchell, R. Sharpe (London, Canada; Nottingham, United Kingdom). Novel non-electrostatic valved holding chamber (VHC) has comparable in vitro performance for delivery of beta-2 agonist as similar-sized, pre-washed but non-conducting VHC. Eur Respir J 2006; 28: Suppl. 50, 1257

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


In vitro performance of a new non-electrostatic, transparent valved holding chamber (VHC) for the poorly coordinated patient
Source: Eur Respir J 2004; 24: Suppl. 48, 380s
Year: 2004

Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005

Substantial in vitro equivalence exists for non-conducting (NC) and anti-static (AS) valved holding chambers (VHCs) provided pre-conditioning of the non-conducting VHC is undertaken
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Is pretreatment of a valved holding chamber (VHC) by priming with medication as effective as washing in ionic detergent?
Source: Eur Respir J 2004; 24: Suppl. 48, 308s
Year: 2004

In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


New anti-static youth valved holding chamber (VHC) can be used out-of-package and deliver β2-agonist medication effectively
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

Non-conducting valved holding chamber (VHC) delivers comparable medication to antistatic metal VHC when manufacturer instructions to precondition are followed
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Performance of a valved holding chamber with tracheostomy adapter: comparison with conventional valved holding chamber
Source: Eur Respir J 2001; 18: Suppl. 33, 134s
Year: 2001

Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rate
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Comparing five antistatic valved holding chambers: how antistatic are they really?
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Are there differences in throat deposition using variable valved holding chambers (VHC)?
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006